INR Management: Adjusting Warfarin Dose Based on Blood Test Results

The International Normalized Ratio (INR) standardizes prothrombin time (PT) to monitor warfarin therapy. Target INR depends on indication.

Common Target INR Ranges

  • Atrial fibrillation, VTE treatment/prevention: 2.0–3.0
  • Mechanical mitral valve, high-risk mechanical aortic valve: 2.5–3.5
  • Mechanical aortic valve (bileaflet, no risk factors): 2.0–3.0
  • Antiphospholipid syndrome (arterial thrombosis): 3.0–4.0

Dose Adjustment Principles

  • INR above target: Bleeding risk ↑ → hold 1–2 doses, reduce weekly dose by 10–20%, recheck in 1–3 days. If INR >5.0 without bleeding: hold warfarin, consider oral vitamin K 1–2.5 mg.
  • INR below target: Thrombosis risk ↑ → increase weekly dose by 10–20%, recheck in 1–2 weeks. If subtherapeutic with thrombosis: bridge with heparin/LMWH.
  • Small, frequent adjustments are better than large swings.

Factors Affecting INR

  • Dietary vitamin K (leafy greens) – consistency is key.
  • Drug interactions (antibiotics, amiodarone, antifungals, NSAIDs, herbals).
  • Alcohol, acute illness, liver function, thyroid status.
  • Adherence.

Monitoring

  • Frequent initially (2–3×/week), then weekly, then every 2–4 weeks when stable.
  • Point-of-care testing enables self-management programs.

Always adjust warfarin under clinician supervision. Never self-adjust without guidance.

Blood Disorders - Related Articles